Simplify Logo

Full-Time

Associate Scientist I

Posted on 4/19/2024

Element Biosciences

Element Biosciences

201-500 employees

Biotechnology firm specializing in DNA sequencing

Biotechnology

Compensation Overview

$79k - $97kAnnually

+ Stock Options + Discretionary Annual Bonus

Entry

San Diego, CA, USA

The job is located at the headquarters in San Diego, CA.

Category
Genomics
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelors degree in chemistry, biochemistry, molecular biology, bioengineering, chemical engineering or a related discipline
  • 3+ years of industry related experience for Bachelor's degree or 1+ years of industry related experience for Master's degree
  • Experience in protein purification using various chromatography methods
  • Experience with AKTA FPLC systems and Unicorn software
  • Capability to develop and qualify biophysical assays
  • Experience in plasmid transformation and expression in E. coli cultures
  • Comfortability with operating 96-well plates and absorbance readers
  • Familiarity with automation technology and programming language
Responsibilities
  • Perform protein purification using AKTA-based column chromatography and high-throughput automation
  • Transformation of target clones and expansion of E. coli bacterial cultures
  • Utilize structure-based design of enzymes to improve manufacturability and stability
  • Perform SDS-PAGE and UV or colorimetric protein concentration measurements
  • Support high-throughput protein engineering screening assays and data analysis
  • Develop methods to characterize stability of enzymes
  • Execute and optimize fluorescence-based assays
  • Maintain good documentation practices
  • Interact with cross-functional departments to support enzymology needs

Element Biosciences specializes in next-generation sequencing (NGS) technology, primarily through its product, the AVITI System. This compact benchtop system provides high-quality DNA sequencing at a low cost, charging only $1 per million reads, which is significantly less than the industry average. The AVITI System is designed to deliver industry-leading accuracy, allowing users, including academic researchers and pharmaceutical companies, to maximize their resources. Element Biosciences differentiates itself from competitors by forming partnerships with other biotech firms, such as QIAGEN, to offer complete NGS workflows, enhancing the value of their product. Additionally, the company runs the 2023 AVITI for All Grant program, which provides free sequencing services for various applications, promoting research and demonstrating the capabilities of the AVITI System. The goal of Element Biosciences is to make high-quality sequencing accessible and affordable for a wide range of users.

Company Stage

Series C

Total Funding

$414M

Headquarters

San Diego, California

Founded

2017

Growth & Insights
Headcount

6 month growth

10%

1 year growth

14%

2 year growth

26%
Simplify Jobs

Simplify's Take

What believers are saying

  • Element Biosciences' recent $277M Series D funding round underscores strong investor confidence and provides substantial resources for growth and innovation.
  • The rapid growth in AVITI System installations, from 20 to over 150 units in a year, indicates strong market adoption and customer satisfaction.
  • The introduction of AVITI24 and Trinity platforms positions Element Biosciences at the forefront of multi-omics and targeted sequencing, potentially revolutionizing research capabilities.

What critics are saying

  • The competitive landscape in NGS technology is intense, with established players potentially overshadowing Element Biosciences' market presence.
  • Rapid expansion and scaling may strain operational capabilities and affect product quality or customer support.

What makes Element Biosciences unique

  • Element Biosciences offers the AVITI System, which provides high-quality sequencing at a significantly lower cost than industry standards, making advanced sequencing more accessible.
  • Strategic partnerships with companies like QIAGEN and Twist Bioscience enhance the AVITI System's capabilities, offering comprehensive NGS workflows and exome sequencing solutions.
  • The company's grant program, AVITI for All, democratizes access to sequencing technology, showcasing the system's capabilities and fostering innovation across various fields.

Help us improve and share your feedback! Did you find this helpful?

Benefits

100% company-paid medical, dental, & vision coverage

Flexible spending & health savings accounts

Premier mental health care

401(k) with immediately vested 4% company match

Company-paid Life and AD&D insurance

Stock option grants

Flexible time off

10 paid annual holidays

8-weeks paid parental leave

INACTIVE